Login to Your Account



Aiming To Enter Clinic In 2005, BioRexis Gets $30M In Series B

By Karen Pihl-Carey


Friday, March 12, 2004
BioRexis Pharmaceutical Corp. attracted new and existing investors with its protein and peptide drug research, raising $30 million in an oversubscribed Series B round. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription